Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: rituximab in combination with methotrexate, cytarabine and dexamethasone Sponsor: Mingzhi Zhang Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dexamethasone | Lymphoma | Methotrexate | Primary CNS Lymphoma | Research | Rituxan | Study